146 related articles for article (PubMed ID: 28340104)
1. Personalizing lung cancer risk prediction and imaging follow-up recommendations using the National Lung Screening Trial dataset.
Hostetter JM; Morrison JJ; Morris M; Jeudy J; Wang KC; Siegel E
J Am Med Inform Assoc; 2017 Nov; 24(6):1046-1051. PubMed ID: 28340104
[TBL] [Abstract][Full Text] [Related]
2. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
[TBL] [Abstract][Full Text] [Related]
3. Addition of the Fleischner Society Guidelines to Chest CT Examination Interpretive Reports Improves Adherence to Recommended Follow-up Care for Incidental Pulmonary Nodules.
McDonald JS; Koo CW; White D; Hartman TE; Bender CE; Sykes AG
Acad Radiol; 2017 Mar; 24(3):337-344. PubMed ID: 27793580
[TBL] [Abstract][Full Text] [Related]
4. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
5. Management of the solitary pulmonary nodule.
Nasim F; Ost DE
Curr Opin Pulm Med; 2019 Jul; 25(4):344-353. PubMed ID: 30973358
[TBL] [Abstract][Full Text] [Related]
6. Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline.
Chen B; Li Q; Hao Q; Tan J; Yan L; Zhu Y; Hu C; Qian G; Zhang G; Chen L; Zhou C; Zhang J; Sun J; Jiang L; Zhang L; Wang Q; Zhang X; Jin Y; He Y; Song Y; Sun X; Li W
J Evid Based Med; 2022 Jun; 15(2):142-151. PubMed ID: 35775869
[TBL] [Abstract][Full Text] [Related]
7. Fleischner Society Guideline Recommendations for Incidentally Detected Pulmonary Nodules and the Probability of Lung Cancer.
Farjah F; Monsell SE; Smith-Bindman R; Gould MK; Banegas MP; Ramaprasan A; Schoen K; Buist DSM; Greenlee R
J Am Coll Radiol; 2022 Nov; 19(11):1226-1235. PubMed ID: 36049538
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
9. Downstream Costs Associated with Incidental Pulmonary Nodules Detected on CT.
Rosenkrantz AB; Xue X; Gyftopoulos S; Kim DC; Nicola GN
Acad Radiol; 2019 Jun; 26(6):798-802. PubMed ID: 30093215
[TBL] [Abstract][Full Text] [Related]
10. "Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society Guidelines.
Heidinger BH; Nemec U; Anderson KR; Costa DB; Gangadharan SP; VanderLaan PA; Bankier AA
Acad Radiol; 2017 Nov; 24(11):1422-1427. PubMed ID: 28666724
[TBL] [Abstract][Full Text] [Related]
11. Management of Incidental Lung Nodules: Current Strategy and Rationale.
Alpert JB; Ko JP
Radiol Clin North Am; 2018 May; 56(3):339-351. PubMed ID: 29622070
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the solitary pulmonary nodule.
Cruickshank A; Stieler G; Ameer F
Intern Med J; 2019 Mar; 49(3):306-315. PubMed ID: 30897667
[TBL] [Abstract][Full Text] [Related]
13. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
[TBL] [Abstract][Full Text] [Related]
14. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
Winter A; Aberle DR; Hsu W
Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
[TBL] [Abstract][Full Text] [Related]
15. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
[TBL] [Abstract][Full Text] [Related]
16. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
17. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
18. Incidental pulmonary nodules in emergent coronary CT angiography for suspected acute coronary syndrome: Impact of revised 2017 Fleischner Society Guidelines.
Scholtz JE; Lu MT; Hedgire S; Meyersohn NM; Oliveira GR; Prabhakar AM; Gupta R; Kalra MK; Shepard JO; Hoffmann U; Ghoshhajra BB
J Cardiovasc Comput Tomogr; 2018; 12(1):28-33. PubMed ID: 29195841
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
